EUSA Pharma bolsters senior leadership team with two appointments

Published on: 15/05/19 Rare disease and oncology biopharma firm EUSA Pharma has revealed two new additions to its senior leadership team in two newly-created roles: Dr Carsten Thiel as President Europe and Dr Darrel P Cohen as Head of Clinical Development. In his new role, Dr Thiel will be responsible for leading EUSA’s growing commercial infrastructure in Europe.